Pre‑procedure Prep Cuts Risks and Speeds Recovery in Heart, Surgery and Cancer Cases

Patients are getting better results when doctors plan key steps before the main operation. New studies show that doing coronary stents (PCI) after a heart‑valve implant, giving iron through a vein before heart surgery, and running a pre‑surgery fitness‑and‑nutrition program before prostate removal each lower complications and help people get home sooner.

Key takeaways

• Doing a transcatheter aortic‑valve implantation (TAVI) before coronary stenting is not worse than the opposite order for one‑year outcomes [1].
• A single dose of intravenous iron before elective heart surgery cuts red‑cell transfusions and adds a few extra days at home in the first 90 days [3].
• Structured pre‑habilitation before radical prostatectomy is feasible, but evidence of benefit is limited [2].

Timing matters for heart‑valve and artery work

About half of patients who need a TAVI – a catheter‑based replacement for a narrowed aortic valve – also have coronary artery disease (blocked heart arteries) [1]. Doctors often place stents (PCI) before the valve, but the best sequence was unclear.

A large international trial compared two strategies: TAVI first then PCI, or PCI first then TAVI. The study enrolled 1,041 patients, with 553 in the TAVI‑first group and 488 in the PCI‑first group [1]. The primary end point combined death, stroke, heart attack, rehospitalisation for heart failure, or need for a new valve or stent within one year [1].

The TAVI‑first group experienced the primary event in 105 patients (22.2%) [1]. The PCI‑first group had 112 events (24.2%) [1]. The risk difference was –2.0 percentage points, and the confidence interval (‑7.4 to 3.4) met the pre‑specified non‑inferiority margin, meaning TAVI first was not worse than PCI first [1]. Serious adverse events occurred in 264 patients in the TAVI‑first arm and 273 in the PCI‑first arm, showing a similar safety profile [1].

These results suggest that doctors may safely schedule the valve replacement before fixing the arteries, which could simplify hospital logistics and reduce the time patients spend with two invasive procedures. The study did not show a clear advantage for either order, so individual patient factors will still guide decisions.

Iron boost before heart surgery cuts blood‑transfusion needs

Anemia (low red‑blood‑cell count) is common before cardiac operations and often leads to blood‑product transfusions, which carry risks [3]. The ITACS trial examined whether a single dose of intravenous iron before surgery could lessen this need.

The double‑blind, placebo‑controlled study recruited 955 adults across 33 hospitals in 10 countries between July 2016 and December 2023 [3]. Participants received either iron or a placebo a few days before elective heart surgery [3].

During the hospital stay, red‑cell transfusions were given to 262 patients (61.1%) in the iron group versus 302 patients (68.2%) in the placebo group [3]. The relative risk was 0.90, with a confidence interval of 0.82 to 0.99, indicating a modest but statistically significant reduction [3].

No differences emerged in major complications or overall length of stay [3]. Patients who got iron stayed alive and at home a few more days within the first 90 days after surgery [3]. The authors concluded that intravenous iron is an effective part of patient‑blood‑management strategies for anaemic patients undergoing cardiac surgery [3].

Pre‑habilitation may smooth the road after prostate removal

Radical prostatectomy (RP) – surgical removal of the prostate gland for cancer – can affect urinary control, sexual function and overall quality of life. Pre‑habilitation aims to improve physical fitness, nutrition and psychological readiness before the operation.

A scoping review gathered evidence on pre‑habilitation programs for RP patients. The authors found that interventions varied widely: some focused on exercise, others added diet counseling or stress‑management workshops. Outcomes measured spanned six domains, including urinary continence, sexual function, physical performance, peri‑operative clinical events, psychological health, health‑related quality of life and nutrition status [2].

Despite this heterogeneity, the review reported that pre‑habilitation was feasible and acceptable across different delivery formats, such as in‑person sessions, home‑based programs or digital platforms [2]. The evidence base was limited by methodological differences and inconsistent outcome measures, and the authors called for high‑quality randomized trials with standardized protocols and core outcome sets [2].

Why proactive care is gaining ground

All three studies share a common theme: moving some of the optimization work to the weeks before the main operation can reduce complications and improve patient‑centered outcomes.

For TAVI and PCI, the non‑inferiority finding supports flexibility in scheduling, potentially lowering the cumulative stress of two procedures performed back‑to‑back. In the iron trial, a simple IV infusion lowered the need for transfusions, which can reduce infection risk and immune reactions. In prostate cancer surgery, the review notes feasibility but does not provide definitive evidence of benefit.

These approaches fit within a broader “patient‑blood‑management” and “enhanced recovery” movement that seeks to tailor care to each individual’s baseline health. By addressing anemia, cardiovascular blockage and physical conditioning before the knife cuts, hospitals may shorten intensive‑care stays, lower costs and improve satisfaction.

Looking ahead

The evidence so far is promising but not definitive. Larger trials are needed to confirm whether TAVI‑first truly offers equal or better long‑term heart outcomes across diverse patient groups. The iron study showed a modest benefit; future work could explore optimal dosing, timing and patient selection. For pre‑habilitation, standardized programs and agreed‑upon outcome measures will be essential to move from feasibility to proven efficacy.

What is clear is that the shift toward pre‑procedure optimization is reshaping how major cardiac and surgical interventions are planned. Patients and families should feel encouraged that researchers are testing ways to make these high‑risk procedures safer and recovery smoother. As more data emerge, proactive preparation may become a routine part of the surgical pathway.